Optimized separation conditions of soy isoflavonoids in urine by capillary zone electrophoresis

Journal of Capillary Electrophoresis and Microchip Technology

Volumn 8, Issue 3-4, 2003, Pages 53-58

  Dabas, Paula C ^a   Báncora, Patricia ^a   Vescina, M Cristina ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Biochanin A; Capillary zone electrophoresis; Daidzein; Genistein

Indexed keywords

BIOCHANIN A; COUMESTAN; DAIDZEIN; GENISTEIN; ISOFLAVONOID; LIGNAN DERIVATIVE; PHYTOESTROGEN; UNCLASSIFIED DRUG;

ACCURACY; ANALYTIC METHOD; ARTICLE; CANCER; CAPILLARY ZONE ELECTROPHORESIS; CIRCADIAN RHYTHM; CORONARY ARTERY DISEASE; DRUG DETERMINATION; DRUG STRUCTURE; HUMAN; MENOPAUSAL SYNDROME; OSTEOPOROSIS; PH; SOLID PHASE EXTRACTION; SOYBEAN; URINALYSIS;

ELECTROPHORESIS, CAPILLARY; HUMANS; HYDROGEN-ION CONCENTRATION; ISOFLAVONES; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOYBEANS; URINALYSIS; URINE;

GLYCINE MAX;

EID: 0344739624     PISSN: 10795383     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Kurzer MS, Xu X. Dietary phytoestrogens. Ann Rev Nutr 1997; 17:353-81.
2. Setchell KDR. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 1998; 68:1333S-46S.
3. Bingham SA, Atkinson C, Liggins J, Bluck L, Coward A. Phytooestrogens: where are we now? Br J Nutr 1998; 79:393-406.
4. Davis SA, Dalais FS, Simpson ER, Murkies AL. Phytoestrogens in health and disease. Rec Prog Hormone Res 1998; 54:185-211.
5. Tham DM, Gardner CD, Haskell WL. Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J Clin Endocrinol Metab 1998; 83:2223-35.
6. Messina MJ. Legumes and soybeans: overview of their nutritional profiles and health effects. Am J Clin Nutr 1999; 70:439S-50S.
7. Wiseman H. The therapeutic potential of phytoestrogens. Exp Opin Invest Drugs 2000; 9:1829-40.
8. Messina M, Barnes S. The role of soy products in reducing cancer risk. J Natl Cancer Inst 1991; 83:541-6.
9. Peterson G, Barnes S. Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene. Biochem Biophys Res Commun 1991; 179:661-7.
10. Messina MJ, Persky V, Setchell KDR, Barnes S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr Cancer 1994; 21:113-31.
11. Knight DC, Eden JA. Phytoestrogens-a short review. Maturitas 1996; 22:167-75.
12. Anthony MS, Clarkson TB, Hughes CL, Morgan TM, Burke GL. Soy bean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peri pubertal rhesus monkeys. J Nutr 1996; 126:43-50.
13. Potter SM, Baum JA, Teng H, Stillman RJ, Shay NF, Erdman JW Jr. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am J Clin Nutr 1998; 68:1375S-9S.
14. Anthony MS, Clarkson TB, Williams JK. Effects of soy isoflavones on atherosclerosis: potential mechanisms. Am J Clin Nutr 1998; 68:1390S-3S.
15. Thiagarajan DG, Bennink MR, Bourquin LD, Kavas FA. Prevention of precancerous colonic lesions in rats by soy flakes, soy flour, genistein, and calcium. Am J Clin Nutr 1998; 68:1394S-9S.
16. Kim H, Peterson TG, Barnes S. Mechanisms of action of the soy isoflavone genistein: emerging role for its effects via transforming growth factor β signaling pathways. Am J Clin Nutr 1998; 68:1418S-25S.
17. Tikkanen MJ, Wähälä K, Ojala S, Vihma V, Aldercreutz H. Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc Natl Acad Sci 1998; 95:3106-10.
18. Barnes S. Evolution of the health benefits of soy isoflavones. Proc Soc Exp Biol Med 1998; 217:386-92.
19. Setchell KDR, Cassidy A. Dietary isoflavones: biological effects and relevance to human health. J Nutr 1999; 129:758S-67S.
20. Washburn S, Burke GL, Morgan T, Anthony M. Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause 1999; 6:7-13.
21. Brzezinski A, Debi Ayelet. Phytoestrogens: the "natural" selective estrogen receptor modulators? Eur J Obstet Gynecol Reprod Biol 1999; 85:47-51.
22. Xu X, Duncan AM, Merz Barbara E, Kurzer MS. Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women. Cancer Epidemiol, Biomark Prev 1998; 7:1101-8.
23. Horn-Ross PL. Phytoestrogens, body composition, and breast cancer. Cancer Causes and Control 1995; 6:567-73.
24. Aldercreutz H, Mazur W, Bartels P, Elomaa VV, Watanabe S, Wähälä K, Landström M, Lundin E, Bergh A, Damber JE, Åman P, Widmark A, Johansson A, Zhang JX, Hallmans G. Phytoestrogens and prostate disease. J Nutr 2000; 130:658S-9S.
25. St. Clair RW. Estrogens and atheroesclerosis: phytoestrogens and selective estrogen receptor modulators. Curr Opin Lipidol 1998; 9:457-63.
26. Tikkanen MJ, Aldercreutz H. Dietary soy-derived isoflavone phytoestrogens. Could they have a role in coronary heart disease prevention? Biochem Pharmacol 2000; 60:1-5.
27. Arjmandi BH, Getlinger MJ, Goyal NV, Alekel L, Hasler CM, Juma S, Drum ML, Hollis BW, Kulreja SC. Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian hormone deficiency in rats. Am J Clin Nutr 1998; 68:1358S-63S.
28. Reinli K, Block G. Phytoestrogen content of foods: a comparison of literature values. Nutr Cancer 1996; 26:123-48.
29. Lampe J, Gustafson D, Hutchins AM, Martini MC, Li S, Wähä lä K, Grandits GA, Potter JD, Slavin JL. Urinary isoflavonoid and lignan excretion on a Western diet: relation to soy, vegetable and fruit intake. Cancer Epidemiol Biomarkers Prev 1999; 8:699-707.
30. Bannwart C, Fotsis T, Heikkinen R, Aldercreutz H. Identification of the isoflavonic phytoestrogen daidzein in human urine. Clin Chim Acta 1984; 136:165-72.
31. Kelly GE, Nelson C, Waring MA, Joannou E, Reeder AY. Metabolites of dietary (soya) isoflavones in human urine. Clin Chim Acta 1993; 223:9-22.
32. Franke AA, Custer LJ, Cerna CM, Narala K. Rapid HPLC analysis of dietary phytoestrogens from legumes and from human urine. Proc Soc Exp biol Med 1995; 208:18-26.
33. Coward L, Kirk M, Albin N, Barnes S. Analysis of plasma isoflavones by reversed-phase HPLC-multiple reaction ion monitoringmass spectrometry. Clin Chim Acta 1996; 247:121-42.
34. Bames S, Coward L, Kirk M, Sfakianos J. HPLC-mass spectrometry analysis of isoflavones. Proc Soc Exp Biol Med 1998; 217:254-62.
35. Stobiecki M, Malosse C, Kerhoas L, Wojlaszek P, Einhorn J. Detection of isoflavonoids and their glycosides by liquid chromatography/electrospray ionization mass spectrometry in root extracts of lupin (Lupinus albus). Phytochem Anal 1999; 17:198-207.
36. Thomas BF, Zisel SH, Busby MG, Hill JM, Mitchell RA, Scheffler NM, Brown SS, Bloeden LT, Dix KJ, Jeffcoat AR. Quantitative analysis of the principle soy isoflavones genistein, daidzein and glycitein, and their primary conjugated metabolites in human plasma and urine using reversed-phase high-performance liquid chromatography with ultraviolet detection. J Chromatogr 2001; 760:191-205.
37. Shihabi ZK, Kute T, Garcia LL, Hinsdale M. Analysis of isoflavones by capillary electrophoresis. J Chromatogr A 1994; 680:181-5.
38. Aramendia MA, Garcia I, Lafont F, Marinas JM. Determination of isoflavones using capillary electrophoresis in combination with electrospray mass spectrometry. J Chromatogr A 1995; 707:327-33.
39. Aussenac T, Lacombe S, Daydé J. Quantification of isoflavones by capillary zone electrophoresis in soybean seeds: effects of variety and environment. Am J Clin Nutr 1998; 68:1480S-5S.
40. Wang CY, Huang HY, Kuo KL, Hsieh YZ, Analysis of Puerariae radix and its medicinal preparations by capillary electrophoresis. J Chromatogr A 1998; 802:225-31.
41. Wang GJ, Lapcik O, Hampl R, Uehara M, Al-Maharik N, Stumpf K, Mikola H, Wähälä K, Aldercreutz H. Time-resolved fluoroimmunoassay of plasma daidzein and genistein. Steroids 2000; 65:339-48.
42. Kohen F, Gayer B, Amir-Zaltsman Y, Ben-Hur H, Thomas E, Lu LJ. A nonisotopic enzyme-based immunoassay for assessing human exposure to genistein. Nutr Cancer 1999; 35:96-103.
43. Lapcik O, Hampl R, Hill M, Wähälä K, Al-Maharik N, Aldercreutz H. Radioimmunoassay of free genistein in human serum J Steroid Biochem Mol Biol 1998; 64:261-8.
44. Blanc T, Schaufelberger DE, Guzman NA. In: Ewing GW, ed. Analytical instrumentation handbook, New York, NY: Marcel Dekker, 1997; chap 27:1351-431.